Mometasone/Formoterol
Brand name: Dulera
Rank #423 of 500 drugs by total cost
$20.4M
Total Cost
46,961
Total Claims
$20.4M
Total Cost
2,599
Prescribers
$434
Cost per Claim
1,680
Beneficiaries
59,772
30-Day Fills
$7,838
Avg Cost/Provider
18
Avg Claims/Provider
About Mometasone/Formoterol
Mometasone/Formoterol (sold as Dulera) was prescribed 46,961 times by 2,599 Medicare Part D providers in 2023, costing the program $20.4M. At $434 per claim, this is a moderately priced medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 420 | Ziprasidone Hcl (Ziprasidone Hcl) | $20.8M | 239,041 |
| 421 | Sodium, Potassium,mag Sulfates (Sod Sulf-Potass Sulf-Mag Sulf) | $20.7M | 246,742 |
| 422 | Efinaconazole (Jublia) | $20.4M | 15,425 |
| 423 | Mometasone/Formoterol (Dulera) | $20.4M | 46,961 |
| 424 | Brinzolamide (Azopt) | $20.1M | 57,322 |
| 425 | Clobazam (Clobazam) | $19.8M | 58,877 |
| 426 | Fluorouracil (Fluorouracil) | $19.5M | 220,445 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology